Two novel determinants of etoposide resistance in small cell lung cancer. - Wikidata - wikimedia - TriplyDB

Two novel determinants of etoposide resistance in small cell lung cancer.

Two novel determinants of etoposide resistance in small cell lung cancer.

http://www.wikidata.org/entity/Q35132390

about

High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.Biological and therapeutic relevance of nonreplicative DNA polymerases to cancer.Hidden treasures in "ancient" microarrays: gene-expression portrays biology and potential resistance pathways of major lung cancer subtypes and normal tissue.Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.

P2860

Q29249058-DF4392F1-27C9-4393-A019-103EB48FE347 Q33787365-5171E268-5A8E-48B3-A9B3-FBD6F5F81D53 Q34994818-42E8F4CF-1518-45BB-B1F1-C3EAFCDA400A Q35984979-CC5CF5A6-AF5E-4197-9CD7-D5171166FDD8 Q37510186-7759889B-DD88-4992-BDE3-B8084469AC02 Q38026112-9E164FEB-9FB4-4659-817C-FA011893D214 Q38471484-0EB5CB7A-4D23-4D27-B618-B52398D96EBF Q45885573-F53F47AE-3561-4377-BF67-1903FDD9E660

P2860

Two novel determinants of etoposide resistance in small cell lung cancer.

http://www.wikidata.org/entity/Q35132390

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Two novel determinants of etoposide resistance in small cell lung cancer.

@ast

Two novel determinants of etoposide resistance in small cell lung cancer.

@en

type

label

Two novel determinants of etoposide resistance in small cell lung cancer.

@ast

Two novel determinants of etoposide resistance in small cell lung cancer.

@en

prefLabel

Two novel determinants of etoposide resistance in small cell lung cancer.

@ast

Two novel determinants of etoposide resistance in small cell lung cancer.

@en

P1433

Q35132390-E5BC6AE6-A30B-4957-9A27-A83F95366615

P1476

Q35132390-B14F1B36-8741-4609-BF13-31F802A2BB13

P2093

Q35132390-0FF3CA95-4025-4531-ADD9-DDD10C46A6DF

Q35132390-37590282-1EED-463A-B95D-57194B6E8EB5

Q35132390-39F1E6F7-DDD6-4B19-8348-CCE1F42D8982

Q35132390-520D1377-EB42-4FA1-9C29-494E3825792C

Q35132390-8A1F8898-270B-435F-92BE-FBC93F131634

P2860

Q35132390-10A8899B-E4E9-4720-8C7E-BFD545A7A55D

Q35132390-11D63E2D-A39C-44F0-A6F2-AFFD787D5818

Q35132390-16379156-783F-4188-A23E-14EB55B91CC4

Q35132390-1C916950-9385-4DE6-82BD-CE0E7FF4F6D8

Q35132390-1D56E389-B3BD-4621-B049-496E8012D6E3

Q35132390-28FEBC6B-1F7E-4841-BE5E-1C17C0D96197

Q35132390-2C53FE95-5DCD-4F3A-B9B7-F3DADA967703

Q35132390-33AACD2B-95DC-4A3D-A3FC-CD858E4F1DEE

Q35132390-3877EAA5-5D56-49F3-8BAD-B6374B139F63

Q35132390-3EA2FD0C-BEAE-4BB8-9A4C-13A891215C58

P304

Q35132390-53D1C681-D09B-41DB-84DF-88D26C7E466F

P31

Q35132390-99E481E6-DD10-4BC4-B94F-3113B35F4FC5

P356

Q35132390-82552497-EDB3-4DFA-9C08-811412D0B37B

P407

Q35132390-225D0A16-6646-43FB-ADDB-C71AACC223F7

P433

Q35132390-B9091148-2CD7-4025-9A58-2E3C6E9FBA18

P478

Q35132390-5C540ED8-643A-42B5-805B-CA2833290B91

P50

Q35132390-7A503150-6EE4-43D8-BF3E-6E7182A42355

Q35132390-FB4A80E2-437F-4492-B9AA-95CCC1DA7E62

P577

Q35132390-0116FC15-7A40-4B9F-B75B-E50B04EDC7DC

P698

Q35132390-37A252B5-6EFE-48E4-A243-A9C56DD0C53A

P932

Q35132390-EAE0DBA3-1AC7-4848-86C1-99B2763A13F7

P356

0008-5472.CAN-11-0080

P1433

Cancer Research

P1476

Two novel determinants of etoposide resistance in small cell lung cancer

@en

P2093

Doris M Rassl

http://www.w3.org/2001/XMLSchema#string

Gillian Murphy

http://www.w3.org/2001/XMLSchema#string

Malcolm H Lawson

http://www.w3.org/2001/XMLSchema#string

Natalie M Cummings

http://www.w3.org/2001/XMLSchema#string

Roslin Russell

http://www.w3.org/2001/XMLSchema#string

P2860

EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma

Platinum versus non-platinum chemotherapy regimens for small cell lung cancer

Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs

Conserved linkage of NK-2 homeobox gene pairs Nkx2-2/2-4 and Nkx2-1/2-9 in mammals

Numerical analysis of etoposide induced DNA breaks

Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells

Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors

Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor

GammaH2AX and cancer

beadarray: R classes and methods for Illumina bead-based data.

P304

4877-4887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-0080

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

James D Brenton

Robert C. Rintoul

P577

2011-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21642373

http://www.w3.org/2001/XMLSchema#string

P932

3145147

http://www.w3.org/2001/XMLSchema#string